We are live on
!
Find out more
Armata Pharmaceuticals
ARMP
ARMP
28 hedge funds and large institutions have $2.27M invested in Armata Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
63% more capital invested
Capital invested by funds: $1.4M → $2.27M (+$875K)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.07% more ownership
Funds ownership: 2.03% → 2.1% (+0.07%)
3% less funds holding
Funds holding: 29 → 28 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$95.6K |
| 2 |
Renaissance Technologies
New York
|
+$6.21K |
| 3 |
MWPCG
Measured Wealth Private Client Group
Portsmouth,
New Hampshire
|
+$2.59K |
| 4 |
BlackRock
New York
|
+$1.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$111 |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$24.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.49K |
| 3 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$2K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$1.9K |
| 5 |
Morgan Stanley
New York
|
-$277 |